Articles by Shinichiro Shinzaki, MD, PhD

Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohn's Disease.

Yoshihara, Takeo; Shinzaki, Shinichiro; Kawai, Shoichiro; More

Inflammatory Bowel Diseases. ., Post Author Corrections: September 22, 2017

Peyer's Patches Play a Protective Role in Nonsteroidal Anti-inflammatory Drug-induced Enteropathy in Mice

Hiyama, Satoshi; Iijima, Hideki; Shinzaki, Shinichiro; More

Inflammatory Bowel Diseases. 20(5):790-799, May 2014.

Lectin-based Immunoassay for Aberrant IgG Glycosylation as the Biomarker for Crohn's Disease

Shinzaki, Shinichiro; Kuroki, Eri; Iijima, Hideki; More

Inflammatory Bowel Diseases. 19(2):321-331, February 2013.

Serum leucine‐rich alpha‐2 glycoprotein is a disease activity biomarker in ulcerative colitis

Serada, Satoshi; Fujimoto, Minoru; Terabe, Fumitaka; More

Inflammatory Bowel Diseases. 18(11):2169-2179, November 2012.

Deficiency of N‐acetylgalactosamine in O‐linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease

Inoue, Takahiro; Iijima, Hideki; Tajiri, Michiko; More

Inflammatory Bowel Diseases. 18(9):1723-1734, September 2012.

Functional analysis of agalactosyl IgG in inflammatory bowel disease patients

Nakajima, Sachiko; Iijima, Hideki; Shinzaki, Shinichiro; More

Inflammatory Bowel Diseases. 17(4):927-936, April 2011.

Comparative analysis of the effects of anti‐IL‐6 receptor mAb and anti‐TNF mAb treatment on CD4+ T‐cell responses in murine colitis

Terabe, Fumitaka; Fujimoto, Minoru; Serada, Satoshi; More

Inflammatory Bowel Diseases. 17(2):491-502, February 2011.